Current Treatment Options in Allergy

Scope & Guideline

Empowering Practitioners with Cutting-Edge Findings

Introduction

Delve into the academic richness of Current Treatment Options in Allergy with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN-
PublisherSPRINGERNATURE
Support Open AccessNo
Country-
Type-
Converge-
AbbreviationCURR TREAT OPTION AL / Curr. Treat. Options Allerg.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressCAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND

Aims and Scopes

The journal 'Current Treatment Options in Allergy' primarily aims to provide a comprehensive platform for the dissemination of contemporary research and clinical practices in the field of allergy and immunology. It focuses on the latest treatment options, emerging therapies, and management strategies pertinent to various allergic conditions.
  1. Comprehensive Allergy Management:
    The journal emphasizes the holistic management of allergic diseases, including pharmacological and non-pharmacological approaches, tailored to individual patient needs.
  2. Innovations in Allergy Treatment:
    It covers cutting-edge advancements in treatment modalities, including biologics, small molecules, and novel immunotherapy approaches that are reshaping the landscape of allergy management.
  3. Interdisciplinary Collaboration:
    The journal promotes multidisciplinary strategies in allergy care, highlighting the importance of collaboration among various specialties such as dermatology, pulmonology, and otolaryngology.
  4. Patient-Centric Perspectives:
    Research focusing on patient experiences, preferences, and outcomes in the context of allergy treatments is a core area, emphasizing the need for patient engagement and education.
  5. Pathophysiological Insights:
    The journal includes studies that delve into the underlying mechanisms of allergic conditions, aiding in the development of targeted therapies.
Recent publications in 'Current Treatment Options in Allergy' indicate a significant shift towards emerging themes that reflect current trends in allergy research and treatment. These themes are gaining attention due to their relevance in contemporary clinical practice.
  1. Biologics and Targeted Therapies:
    There is a marked increase in research focused on the development and application of biologics, which offer targeted treatment options for severe allergic conditions, including asthma and chronic rhinosinusitis.
  2. Impact of the Microbiome:
    Studies exploring the role of the microbiome in allergic diseases are on the rise, highlighting its potential influence on disease pathogenesis and treatment responses.
  3. Psychological Factors in Allergy Management:
    Recent papers are emphasizing the psychological aspects of allergy, such as the impact of stress on conditions like urticaria, indicating a growing recognition of the mind-body connection in allergic disease.
  4. Food Allergies and Novel Therapies:
    Research on food allergies, particularly emerging therapies and immunotherapy approaches, is trending, reflecting an urgent need to address the rising prevalence of food allergies.
  5. Multidisciplinary Approaches in Treatment:
    There is a growing trend towards an integrated approach in managing allergic diseases, involving collaboration among various medical specialties to optimize patient outcomes.

Declining or Waning

As the field of allergy research evolves, certain themes and topics have shown a decline in prominence within recent publications in 'Current Treatment Options in Allergy'. These waning scopes reflect shifts in research priorities and clinical practice.
  1. Traditional Allergy Testing Methods:
    There has been a noticeable decrease in studies focusing on conventional allergy testing methods, such as skin prick tests and serum IgE testing, as more advanced techniques and personalized approaches gain traction.
  2. Generalized Management of Asthma:
    While asthma remains a key topic, the focus on broad, non-specific management strategies is diminishing in favor of precision medicine approaches tailored to specific phenotypes and endotypes.
  3. Pediatric Allergy Management:
    Research specifically addressing pediatric allergies is becoming less frequent, possibly due to a growing emphasis on adult populations and the need for age-specific treatment protocols.
  4. Environmental Allergens and Seasonal Allergies:
    Although still relevant, studies focusing on environmental triggers and seasonal allergies are less prominent compared to the exploration of systemic and chronic allergic conditions.
  5. Historical Allergy Therapies:
    There is a waning interest in older treatment modalities, as the field shifts towards exploring novel therapies and biologics that offer better efficacy and safety profiles.

Similar Journals

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA

Elevating Standards in Otolaryngologic Care
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0030-6665Frequency: 6 issues/year

OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, published by W B SAUNDERS CO-ELSEVIER INC, is a prestigious journal dedicated to the field of otorhinolaryngology. With a rich history spanning from 1970 to the present, this journal serves as a crucial resource for medical professionals, researchers, and students interested in the latest developments and treatment modalities in ear, nose, and throat disorders. While the journal does not currently offer open access, it maintains a reputable standing in the academic community, reflected in its 2023 category quartile rankings, placing it in Q3 for Medicine (miscellaneous) and Q2 for Otorhinolaryngology. Furthermore, it ranks #53 out of 123 in the Medicine - Otorhinolaryngology category in Scopus, encompassing the 57th percentile. Researchers and practitioners turn to this journal for insightful articles that contribute to the advancement of clinical practice and enhance patient care.

CLINICAL AND EXPERIMENTAL ALLERGY

Exploring Innovative Solutions in Allergy and Immunology
Publisher: WILEYISSN: 0954-7894Frequency: 12 issues/year

CLINICAL AND EXPERIMENTAL ALLERGY is a premier peer-reviewed journal dedicated to advancing the scientific understanding of allergy and immunology. Published by Wiley in the United Kingdom, this esteemed journal maintains a significant impact factor, reflecting its high standards and influential research contributions. With an impressive history since its inception in 1971, the journal is poised to continue leading the discourse in the field until at least 2024. It is ranked in the Q2 quartile for both Immunology and Allergy categories, further highlighting its reputable standing within the academic community. The journal's Scopus rankings showcase its academic relevance, securing the 49th and 51st positions in the Medicine and Immunology categories, respectively. Researchers, professionals, and students will find vital insights and contemporary research trends within its pages, making it an essential resource for those invested in understanding and addressing allergic diseases and disorders.

Current Allergy & Clinical Immunology

Exploring breakthroughs in allergic condition treatments.
Publisher: ALLERGY SOC SOUTH AFRICAISSN: 1609-3607Frequency: 4 issues/year

Current Allergy & Clinical Immunology is a vital peer-reviewed journal published by the Allergy Society of South Africa, focused on advancing the field of immunology and allergy medicine. With an ISSN of 1609-3607, this journal offers crucial insights and research findings pertinent to the understanding and treatment of allergic conditions. Operating from South Africa, it features contributions from a diverse range of authors and professionals in the field. Published from 2008 to 2024, the journal plays an essential role in disseminating current knowledge, even as it holds a Q4 ranking in Immunology and Allergy and is positioned at the 4th percentile based on Scopus rankings. While not open access, it remains an important resource for researchers, practitioners, and students looking to stay informed on emerging trends and breakthroughs in allergy and clinical immunology.

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY

Exploring the frontiers of Allergy and Clinical Immunology.
Publisher: ESMON PUBLICIDAD S A, DEPT ALLERGY & CLIN IMMUNOL, CLIN UNIV NAVARRAISSN: 1018-9068Frequency: 6 issues/year

JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is an esteemed publication dedicated to the fields of Immunology and Allergy, published by ESMON PUBLICIDAD S A in collaboration with the Department of Allergy and Clinical Immunology at the University Clinical Navarra, Spain. With its rich history spanning over three decades since its inception in 1991, this journal has gained prominence in the scientific community, holding a commendable Q2 quartile in Allergy and a Q3 quartile in Immunology. Ranked within the top tiers of its categories according to Scopus, it stands at Rank #80/233 in Immunology and Allergy, and Rank #96/236 in Immunology and Microbiology, indicating its influential role in disseminating cutting-edge research and clinical insights. Though primarily print-focused, the journal strives to bridge gaps in knowledge and contribute to the ongoing dialogue among researchers, professionals, and students in the immunological sciences. The JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY is essential for anyone committed to advancing the understanding of allergic and immunological conditions.

Allergy & Rhinology

Fostering collaboration in the fields of immunology and otorhinolaryngology.
Publisher: SAGE PUBLICATIONS INCISSN: 2152-6567Frequency: 1 issue/year

Allergy & Rhinology, published by SAGE Publications Inc, is a premier open access journal that has been disseminating critical research since 2011. With a dedicated ISSN of 2152-6567 and an E-ISSN of 2152-6567, this journal serves as an essential platform for scholars in the fields of immunology, allergy, and otorhinolaryngology. Recognized in the 2023 Scopus rankings, it holds a Q3 category in Immunology and Allergy and a Q2 category in Otorhinolaryngology, reflecting its commitment to high-quality research. The journal not only supports the sharing of innovative research ideas and practices but also ensures broader access to new developments within these vital fields, appealing to researchers, clinicians, and students alike. With its headquarters in the United Kingdom and an address in Thousand Oaks, California, Allergy & Rhinology continues to contribute significantly to the advancement of knowledge, helping professionals tackle pressing issues related to allergies and respiratory conditions.

Journal of Asthma and Allergy

Exploring innovative solutions for respiratory challenges.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-6965Frequency: 1 issue/year

The Journal of Asthma and Allergy, published by DOVE MEDICAL PRESS LTD, is a leading open-access journal dedicated to advancing research in the fields of immunology, allergy, and pulmonary medicine. Since its inception in 2008, this journal has provided a vital platform for disseminating high-quality, peer-reviewed research that explores the complexities of asthma and allergy, allowing researchers, professionals, and students to access critical insights without subscription barriers. With an impressive impact factor reflected in its 2023 quartile rankings (Q2) in both Immunology and Allergy, as well as Pulmonary and Respiratory Medicine, the journal stands as a significant contributor to the scientific community, promoting innovative findings that support clinical practice and patient care. Based in New Zealand, the Journal of Asthma and Allergy continues to be at the forefront of research, from its dedication to publishing cutting-edge studies to fostering an inclusive academic discourse that spans the globe. Access to relevant articles is available online, ensuring that all stakeholders in these fields can stay informed and engaged.

AIMS Allergy and Immunology

Fostering Excellence in Allergy and Immunology Scholarship
Publisher: AMER INST MATHEMATICAL SCIENCES-AIMSISSN: 2575-615XFrequency: 4 issues/year

AIMS Allergy and Immunology is a prestigious open access journal dedicated to advancing knowledge in the fields of allergy and immunology. Published by the American Institute of Mathematical Sciences (AIMS), this journal provides a vibrant platform for researchers, practitioners, and scholars to share groundbreaking findings and insights. Recognized for its commitment to disseminating high-quality research since its inception in 2017, AIMS Allergy and Immunology contributes significantly to the understanding of complex immunological mechanisms and allergic responses, thus playing a pivotal role in enhancing clinical practices and therapeutic strategies. With its ISSN 2575-615X, the journal aims to facilitate a robust exchange of ideas and promote collaboration within the scientific community. Researchers and practitioners are encouraged to access the latest studies and reviews, which are all freely available online, ensuring that vital information reaches a global audience without barriers. Together, we can tackle the challenges posed by allergies and immune disorders through rigorous scientific inquiry and innovation.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Empowering Clinicians with Evidence-Based Knowledge
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0889-8561Frequency: 4 issues/year

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, focusing on the dynamic fields of immunology and allergy. With an ISSN of 0889-8561 and an E-ISSN of 1557-8607, this journal has consistently ranked in the Q2 category in both Immunology and Immunology and Allergy as per 2023 metrics, underscoring its critical role in academia. It provides cutting-edge research, comprehensive reviews, and practical insights that cater to the needs of researchers, clinicians, and students alike. Though the journal is not open access, it remains an essential resource for those involved in advancing knowledge and clinical practice in allergy and immunology. With its converged years stretching from 1987 to 2024, the journal serves as a rich repository of scientific advancements, fostering progress in diagnosis, treatment, and prevention of allergic diseases and immune disorders. Positioned within the United States and based in Philadelphia, it plays a vital role in promoting scholarly communication within these impactful fields.

Reumatologia

Fostering collaboration in the fields of Immunology and Rheumatology.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 0034-6233Frequency: 6 issues/year

Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.

Allergo Journal

Exploring the frontiers of allergenic research.
Publisher: SPRINGER HEIDELBERGISSN: 0941-8849Frequency: 8 issues/year

Welcome to the Allergo Journal, a pivotal publication in the field of Immunology and Allergy, housed under the esteemed SPRINGER HEIDELBERG publishing house. With an ISSN of 0941-8849 and E-ISSN 2195-6405, the journal has been serving the scientific community since its inception in 1994. Although its Scopus coverage was discontinued in 2017, the journal remains significant, ranked #135 out of 186 in its category and positioned in the 27th percentile, reflecting its contributions to vital research in allergy and immunological disorders. While the journal is not an open access publication, it continues to provide a platform for rigorous academic discourse and advances in the study of allergens and immune response. The Allergo Journal stands as a crucial resource for researchers, professionals, and students dedicated to deepening their understanding of allergies and immunology, fostering advancements in therapy and comprehensive patient care.